nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—Ovarian cancer—Docetaxel—head and neck cancer	0.0445	0.0659	CcSEcCtD
Estriol—Breast cancer—Docetaxel—head and neck cancer	0.0212	0.0314	CcSEcCtD
Estriol—ESR2—Nuclear Receptors—RARB—head and neck cancer	0.0177	0.0554	CbGpPWpGaD
Estriol—Tenderness—Hydroxyurea—head and neck cancer	0.017	0.0252	CcSEcCtD
Estriol—Neoplasm—Vinblastine—head and neck cancer	0.0147	0.0218	CcSEcCtD
Estriol—ESR2—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.014	0.0438	CbGpPWpGaD
Estriol—Menstruation irregular—Docetaxel—head and neck cancer	0.0139	0.0207	CcSEcCtD
Estriol—Neoplasm—Hydroxyurea—head and neck cancer	0.0134	0.0199	CcSEcCtD
Estriol—Polyp—Docetaxel—head and neck cancer	0.0127	0.0188	CcSEcCtD
Estriol—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0127	0.0188	CcSEcCtD
Estriol—Tenderness—Fluorouracil—head and neck cancer	0.0123	0.0182	CcSEcCtD
Estriol—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0121	0.0179	CcSEcCtD
Estriol—Cyst—Docetaxel—head and neck cancer	0.0115	0.0171	CcSEcCtD
Estriol—ESR1—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.0108	0.0337	CbGpPWpGaD
Estriol—SHBG—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00998	0.0313	CbGpPWpGaD
Estriol—Breast disorder—Hydroxyurea—head and neck cancer	0.00974	0.0144	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.0095	0.0297	CbGpPWpGaD
Estriol—Depression—Vinblastine—head and neck cancer	0.00909	0.0135	CcSEcCtD
Estriol—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00898	0.0133	CcSEcCtD
Estriol—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00897	0.0133	CcSEcCtD
Estriol—Myocardial infarction—Vinblastine—head and neck cancer	0.00893	0.0132	CcSEcCtD
Estriol—ESR1—Nuclear Receptors—RARB—head and neck cancer	0.00892	0.0279	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—XRCC1—head and neck cancer	0.00863	0.027	CbGpPWpGaD
Estriol—Bone disorder—Docetaxel—head and neck cancer	0.00854	0.0127	CcSEcCtD
Estriol—Weight increased—Hydroxyurea—head and neck cancer	0.00848	0.0126	CcSEcCtD
Estriol—Infestation NOS—Hydroxyurea—head and neck cancer	0.00831	0.0123	CcSEcCtD
Estriol—Infestation—Hydroxyurea—head and neck cancer	0.00831	0.0123	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00824	0.0258	CbGpPWpGaD
Estriol—ESR1—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.00794	0.0249	CbGpPWpGaD
Estriol—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00786	0.0116	CcSEcCtD
Estriol—Pulmonary embolism—Docetaxel—head and neck cancer	0.00772	0.0114	CcSEcCtD
Estriol—Blood pressure increased—Docetaxel—head and neck cancer	0.00772	0.0114	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—TGFA—head and neck cancer	0.00765	0.024	CbGpPWpGaD
Estriol—SHBG—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00762	0.0239	CbGpPWpGaD
Estriol—Fluid retention—Docetaxel—head and neck cancer	0.00733	0.0109	CcSEcCtD
Estriol—Alopecia—Vinblastine—head and neck cancer	0.00723	0.0107	CcSEcCtD
Estriol—ESR1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00705	0.0221	CbGpPWpGaD
Estriol—Neoplasm—Docetaxel—head and neck cancer	0.00698	0.0103	CcSEcCtD
Estriol—Angiopathy—Hydroxyurea—head and neck cancer	0.00677	0.01	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00673	0.0211	CbGpPWpGaD
Estriol—Alopecia—Hydroxyurea—head and neck cancer	0.00659	0.00977	CcSEcCtD
Estriol—Thrombophlebitis—Docetaxel—head and neck cancer	0.00647	0.00959	CcSEcCtD
Estriol—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00618	0.00916	CcSEcCtD
Estriol—Hypertension—Vinblastine—head and neck cancer	0.00615	0.00911	CcSEcCtD
Estriol—Infestation—Fluorouracil—head and neck cancer	0.00598	0.00887	CcSEcCtD
Estriol—Infestation NOS—Fluorouracil—head and neck cancer	0.00598	0.00887	CcSEcCtD
Estriol—Visual disturbance—Docetaxel—head and neck cancer	0.00591	0.00876	CcSEcCtD
Estriol—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.0059	0.00874	CcSEcCtD
Estriol—Myocardial infarction—Fluorouracil—head and neck cancer	0.00586	0.00869	CcSEcCtD
Estriol—Migraine—Docetaxel—head and neck cancer	0.00551	0.00817	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00549	0.00814	CcSEcCtD
Estriol—Oedema—Hydroxyurea—head and neck cancer	0.0053	0.00786	CcSEcCtD
Estriol—Infection—Hydroxyurea—head and neck cancer	0.00527	0.0078	CcSEcCtD
Estriol—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0052	0.0077	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00516	0.0162	CbGpPWpGaD
Estriol—Skin disorder—Hydroxyurea—head and neck cancer	0.00515	0.00763	CcSEcCtD
Estriol—Breast disorder—Docetaxel—head and neck cancer	0.00506	0.0075	CcSEcCtD
Estriol—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00499	0.0156	CbGpPWpGaD
Estriol—Pain—Vinblastine—head and neck cancer	0.00497	0.00737	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00486	0.0152	CbGpPWpGaD
Estriol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00475	0.00704	CcSEcCtD
Estriol—Alopecia—Fluorouracil—head and neck cancer	0.00475	0.00703	CcSEcCtD
Estriol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00467	0.00691	CcSEcCtD
Estriol—Abdominal pain—Vinblastine—head and neck cancer	0.00459	0.00681	CcSEcCtD
Estriol—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00458	0.00678	CcSEcCtD
Estriol—Pain—Hydroxyurea—head and neck cancer	0.00453	0.00672	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00442	0.0138	CbGpPWpGaD
Estriol—Weight increased—Docetaxel—head and neck cancer	0.00441	0.00653	CcSEcCtD
Estriol—Weight decreased—Docetaxel—head and neck cancer	0.00438	0.00649	CcSEcCtD
Estriol—Infestation—Docetaxel—head and neck cancer	0.00432	0.0064	CcSEcCtD
Estriol—Infestation NOS—Docetaxel—head and neck cancer	0.00432	0.0064	CcSEcCtD
Estriol—Hypersensitivity—Vinblastine—head and neck cancer	0.00428	0.00635	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.00427	0.0134	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00427	0.0134	CbGpPWpGaD
Estriol—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00426	0.00631	CcSEcCtD
Estriol—Myocardial infarction—Docetaxel—head and neck cancer	0.00423	0.00627	CcSEcCtD
Estriol—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00408	0.00605	CcSEcCtD
Estriol—Diarrhoea—Vinblastine—head and neck cancer	0.00398	0.00589	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00392	0.0123	CbGpPWpGaD
Estriol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0039	0.00579	CcSEcCtD
Estriol—Dizziness—Vinblastine—head and neck cancer	0.00384	0.0057	CcSEcCtD
Estriol—Oedema peripheral—Docetaxel—head and neck cancer	0.00382	0.00566	CcSEcCtD
Estriol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00381	0.00565	CcSEcCtD
Estriol—Oedema—Fluorouracil—head and neck cancer	0.00381	0.00565	CcSEcCtD
Estriol—Connective tissue disorder—Docetaxel—head and neck cancer	0.00381	0.00564	CcSEcCtD
Estriol—Infection—Fluorouracil—head and neck cancer	0.00379	0.00562	CcSEcCtD
Estriol—Nervous system disorder—Fluorouracil—head and neck cancer	0.00374	0.00554	CcSEcCtD
Estriol—Visual impairment—Docetaxel—head and neck cancer	0.00373	0.00554	CcSEcCtD
Estriol—Vomiting—Vinblastine—head and neck cancer	0.0037	0.00548	CcSEcCtD
Estriol—Erythema multiforme—Docetaxel—head and neck cancer	0.00366	0.00543	CcSEcCtD
Estriol—Headache—Vinblastine—head and neck cancer	0.00364	0.0054	CcSEcCtD
Estriol—Diarrhoea—Hydroxyurea—head and neck cancer	0.00363	0.00537	CcSEcCtD
Estriol—Eye disorder—Docetaxel—head and neck cancer	0.00362	0.00537	CcSEcCtD
Estriol—Cardiac disorder—Docetaxel—head and neck cancer	0.0036	0.00533	CcSEcCtD
Estriol—Angiopathy—Docetaxel—head and neck cancer	0.00352	0.00521	CcSEcCtD
Estriol—Dizziness—Hydroxyurea—head and neck cancer	0.0035	0.00519	CcSEcCtD
Estriol—Immune system disorder—Docetaxel—head and neck cancer	0.0035	0.00519	CcSEcCtD
Estriol—Estrone—CYP1A1—head and neck cancer	0.00346	0.569	CrCbGaD
Estriol—Nausea—Vinblastine—head and neck cancer	0.00345	0.00512	CcSEcCtD
Estriol—Insomnia—Fluorouracil—head and neck cancer	0.00345	0.00511	CcSEcCtD
Estriol—Alopecia—Docetaxel—head and neck cancer	0.00342	0.00508	CcSEcCtD
Estriol—Mental disorder—Docetaxel—head and neck cancer	0.0034	0.00503	CcSEcCtD
Estriol—Malnutrition—Docetaxel—head and neck cancer	0.00337	0.005	CcSEcCtD
Estriol—Vomiting—Hydroxyurea—head and neck cancer	0.00337	0.00499	CcSEcCtD
Estriol—Dyspepsia—Fluorouracil—head and neck cancer	0.00336	0.00498	CcSEcCtD
Estriol—Rash—Hydroxyurea—head and neck cancer	0.00334	0.00495	CcSEcCtD
Estriol—Dermatitis—Hydroxyurea—head and neck cancer	0.00334	0.00495	CcSEcCtD
Estriol—Headache—Hydroxyurea—head and neck cancer	0.00332	0.00492	CcSEcCtD
Estriol—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00329	0.00488	CcSEcCtD
Estriol—Back pain—Docetaxel—head and neck cancer	0.00326	0.00484	CcSEcCtD
Estriol—Pain—Fluorouracil—head and neck cancer	0.00326	0.00484	CcSEcCtD
Estriol—Muscle spasms—Docetaxel—head and neck cancer	0.00324	0.00481	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00321	0.01	CbGpPWpGaD
Estriol—Nausea—Hydroxyurea—head and neck cancer	0.00315	0.00467	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00312	0.00976	CbGpPWpGaD
Estriol—Urticaria—Fluorouracil—head and neck cancer	0.00303	0.00449	CcSEcCtD
Estriol—Hypertension—Docetaxel—head and neck cancer	0.00291	0.00432	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.0029	0.00908	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.00288	0.00903	CbGpPWpGaD
Estriol—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.00288	0.00901	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00286	0.00897	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00285	0.00423	CcSEcCtD
Estriol—Hypersensitivity—Fluorouracil—head and neck cancer	0.00281	0.00417	CcSEcCtD
Estriol—Anaphylactic shock—Docetaxel—head and neck cancer	0.00275	0.00408	CcSEcCtD
Estriol—Oedema—Docetaxel—head and neck cancer	0.00275	0.00408	CcSEcCtD
Estriol—Infection—Docetaxel—head and neck cancer	0.00274	0.00405	CcSEcCtD
Estriol—Shock—Docetaxel—head and neck cancer	0.00271	0.00402	CcSEcCtD
Estriol—Nervous system disorder—Docetaxel—head and neck cancer	0.0027	0.004	CcSEcCtD
Estriol—Pruritus—Fluorouracil—head and neck cancer	0.0027	0.004	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00269	0.00843	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.00268	0.00838	CbGpPWpGaD
Estriol—Skin disorder—Docetaxel—head and neck cancer	0.00267	0.00396	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00265	0.00832	CbGpPWpGaD
Estriol—Estradiol—CYP1A1—head and neck cancer	0.00262	0.431	CrCbGaD
Estriol—Diarrhoea—Fluorouracil—head and neck cancer	0.00261	0.00387	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.00255	0.00798	CbGpPWpGaD
Estriol—Dizziness—Fluorouracil—head and neck cancer	0.00252	0.00374	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.0025	0.00782	CbGpPWpGaD
Estriol—Insomnia—Docetaxel—head and neck cancer	0.00249	0.00369	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00245	0.00768	CbGpPWpGaD
Estriol—Vomiting—Fluorouracil—head and neck cancer	0.00243	0.0036	CcSEcCtD
Estriol—Dyspepsia—Docetaxel—head and neck cancer	0.00242	0.00359	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—RARB—head and neck cancer	0.00241	0.00756	CbGpPWpGaD
Estriol—Rash—Fluorouracil—head and neck cancer	0.00241	0.00357	CcSEcCtD
Estriol—Dermatitis—Fluorouracil—head and neck cancer	0.0024	0.00356	CcSEcCtD
Estriol—Headache—Fluorouracil—head and neck cancer	0.00239	0.00354	CcSEcCtD
Estriol—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00238	0.00352	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00236	0.00741	CbGpPWpGaD
Estriol—Pain—Docetaxel—head and neck cancer	0.00235	0.00349	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00233	0.0073	CbGpPWpGaD
Estriol—Nausea—Fluorouracil—head and neck cancer	0.00227	0.00336	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.00226	0.00709	CbGpPWpGaD
Estriol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00225	0.00334	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00223	0.00698	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—YAP1—head and neck cancer	0.0022	0.00688	CbGpPWpGaD
Estriol—Abdominal pain—Docetaxel—head and neck cancer	0.00218	0.00323	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.00204	0.00639	CbGpPWpGaD
Estriol—Hypersensitivity—Docetaxel—head and neck cancer	0.00203	0.00301	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00201	0.0063	CbGpPWpGaD
Estriol—Pruritus—Docetaxel—head and neck cancer	0.00195	0.00289	CcSEcCtD
Estriol—Diarrhoea—Docetaxel—head and neck cancer	0.00188	0.00279	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00183	0.00575	CbGpPWpGaD
Estriol—Dizziness—Docetaxel—head and neck cancer	0.00182	0.0027	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00181	0.00568	CbGpPWpGaD
Estriol—Vomiting—Docetaxel—head and neck cancer	0.00175	0.00259	CcSEcCtD
Estriol—Rash—Docetaxel—head and neck cancer	0.00174	0.00257	CcSEcCtD
Estriol—Dermatitis—Docetaxel—head and neck cancer	0.00173	0.00257	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00173	0.0054	CbGpPWpGaD
Estriol—Headache—Docetaxel—head and neck cancer	0.00172	0.00256	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00172	0.0054	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00166	0.00521	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00165	0.00517	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00165	0.00517	CbGpPWpGaD
Estriol—Nausea—Docetaxel—head and neck cancer	0.00164	0.00242	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00162	0.00506	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.00158	0.00495	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00157	0.00492	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00156	0.00488	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00154	0.00483	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00154	0.00482	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.0015	0.00471	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—UROD—head and neck cancer	0.00148	0.00464	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00148	0.00463	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.00146	0.00458	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.00145	0.00455	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00145	0.00455	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.00142	0.00446	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.00142	0.00446	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00137	0.00429	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.00135	0.00424	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00134	0.00419	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.00134	0.00419	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.00133	0.00415	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.0013	0.00406	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00129	0.00404	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.00128	0.00402	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.00127	0.00398	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.00123	0.00385	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.00122	0.00381	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00121	0.00378	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.00121	0.00378	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00118	0.00369	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.00117	0.00368	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00117	0.00365	CbGpPWpGaD
Estriol—ESR2—Gene Expression—RARB—head and neck cancer	0.00116	0.00364	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00115	0.0036	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.00112	0.0035	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.00111	0.00347	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.0011	0.00346	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.0011	0.00345	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00109	0.00342	CbGpPWpGaD
Estriol—ESR2—Gene Expression—YAP1—head and neck cancer	0.00106	0.00331	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00105	0.00329	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00105	0.00328	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000991	0.0031	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00099	0.0031	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000981	0.00307	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000948	0.00297	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000915	0.00287	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.00091	0.00285	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000897	0.00281	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00088	0.00276	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000856	0.00268	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000813	0.00255	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000792	0.00248	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000785	0.00246	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000785	0.00246	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000781	0.00245	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000746	0.00234	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000745	0.00233	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000743	0.00233	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000741	0.00232	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000727	0.00228	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000712	0.00223	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000709	0.00222	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000708	0.00222	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000674	0.00211	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000667	0.00209	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000654	0.00205	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00065	0.00204	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000647	0.00203	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000638	0.002	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000638	0.002	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000635	0.00199	CbGpPWpGaD
Estriol—ABCB1—Metabolism—UROD—head and neck cancer	0.000635	0.00199	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000635	0.00199	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.00063	0.00197	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NAT2—head and neck cancer	0.000616	0.00193	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000587	0.00184	CbGpPWpGaD
Estriol—ESR1—Gene Expression—RARB—head and neck cancer	0.000586	0.00184	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000556	0.00174	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000551	0.00173	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—DPYD—head and neck cancer	0.00054	0.00169	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000536	0.00168	CbGpPWpGaD
Estriol—ESR1—Gene Expression—YAP1—head and neck cancer	0.000533	0.00167	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000529	0.00166	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000529	0.00166	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—YAP1—head and neck cancer	0.000512	0.0016	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.00051	0.0016	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000499	0.00156	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.00049	0.00153	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000484	0.00152	CbGpPWpGaD
Estriol—ESR2—Gene Expression—NOTCH1—head and neck cancer	0.000476	0.00149	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000464	0.00145	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000459	0.00144	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000452	0.00142	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.00045	0.00141	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000444	0.00139	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000415	0.0013	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000403	0.00126	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000395	0.00124	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000392	0.00123	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000385	0.00121	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000375	0.00117	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000357	0.00112	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000347	0.00109	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000344	0.00108	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000336	0.00105	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000311	0.000974	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TYMS—head and neck cancer	0.000308	0.000964	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTM1—head and neck cancer	0.000304	0.000953	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000294	0.000921	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GPX1—head and neck cancer	0.000291	0.000912	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	0.000288	0.000903	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00028	0.000876	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00028	0.000876	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MAPK3—head and neck cancer	0.000264	0.000826	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NAT2—head and neck cancer	0.000264	0.000826	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000243	0.000761	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.00024	0.000753	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000237	0.000742	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000235	0.000736	CbGpPWpGaD
Estriol—ABCB1—Metabolism—DPYD—head and neck cancer	0.000231	0.000724	CbGpPWpGaD
Estriol—ABCB1—Metabolism—YAP1—head and neck cancer	0.000219	0.000687	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000198	0.000621	CbGpPWpGaD
Estriol—ESR2—Gene Expression—AKT1—head and neck cancer	0.000178	0.000557	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTGS2—head and neck cancer	0.000171	0.000537	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000156	0.000489	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTEN—head and neck cancer	0.000149	0.000468	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MAPK3—head and neck cancer	0.000133	0.000416	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TYMS—head and neck cancer	0.000132	0.000413	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTM1—head and neck cancer	0.00013	0.000408	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GPX1—head and neck cancer	0.000125	0.000391	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP1A1—head and neck cancer	0.000123	0.000387	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL2—head and neck cancer	0.000107	0.000337	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	0.000105	0.00033	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCND1—head and neck cancer	0.000105	0.000328	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTEN—head and neck cancer	0.000101	0.000317	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VEGFA—head and neck cancer	9.14e-05	0.000286	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—STAT3—head and neck cancer	9.05e-05	0.000283	CbGpPWpGaD
Estriol—ESR1—Gene Expression—AKT1—head and neck cancer	8.97e-05	0.000281	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MAPK3—head and neck cancer	8.64e-05	0.000271	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKT1—head and neck cancer	8.62e-05	0.00027	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MAPK1—head and neck cancer	8.22e-05	0.000258	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—head and neck cancer	8.22e-05	0.000258	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTGS2—head and neck cancer	7.34e-05	0.00023	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	7.14e-05	0.000224	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—head and neck cancer	6.9e-05	0.000216	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—head and neck cancer	6.6e-05	0.000207	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTEN—head and neck cancer	6.4e-05	0.0002	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKT1—head and neck cancer	5.83e-05	0.000183	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.51e-05	0.000141	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKT1—head and neck cancer	3.69e-05	0.000116	CbGpPWpGaD
